搜尋結果
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 3 日前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...
Hims & Hers Stock Hits 3-Year High After Announcing $199 Weight-Loss Alternative To Wegovy
Forbes· 4 日前Shares of telehealth company Hims & Hers Health closed at a three-year high Monday after the ...
Hims Debuts $199 Weight-Loss Shots at 85% Discount to Wegovy
Bloomberg· 3 日前Have a confidential tip for our reporters? In just a few years, Hims & Hers Health Inc. reached ...
Memorial Day Inflation: Travel, BBQ, And Booze All Cost More This Year
Forbes· 6 日前Inflation may be more palatable than years past heading into this Memorial Day Weekend, but ...
WitnessAI is building guardrails for generative AI models
TechCrunch· 2 日前Generative AI makes stuff up. Rick Caccia, the CEO of WitnessAI, believes it can. “Securing AI ...
U.S. Natural Gas Futures Resume Rally
The Wall Street Journal· 1 日前The EIA is expected to report a third straight below-average build in underground storage for last week, continuing to erode ...
Council Post: Three Questions Every Leader Needs To Ask About AI Cybersecurity
Forbes· 2 日前Kasada CTO, stopping bot attacks that others can't stop with novel mitigation techniques that beat cybercriminals at their ...
用於開發人工智慧系統的Python套件存在重大漏洞,恐導致系統資料外流
iThome· 4 日前研究人員針對Python套件llama_cpp_python漏洞「Llama Drama(CVE-2024-34359)」提出警告,並指出在人工智慧社群平臺Hugging Face上,就有超過6千個模型可 ...
Kretinsky weighs changes to Atos bid to win over creditors, source says
Reuters· 2 日前, opens new tab, a source close to the matter said, as the distressed IT firm seeks a debt ...
EU regulator scraps approval for pregnancy drug over cancer risk
Reuters· 6 日前The European Medicines Agency (EMA) on Friday recommended scrapping approval for a drug used to ...